Business Context and Reporting Period
This Form 8-K was filed by Actinium Pharmaceuticals, Inc. (formerly Cactus Ventures, Inc.) on April 11, 2013. The report details a corporate restructuring effective on the filing date, involving a change of domicile from Nevada to Delaware and a name change.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes rather than financial performance.
Material Changes
- Corporate Domicile: Changed from the State of Nevada to the State of Delaware.
- Company Name: Changed from Cactus Ventures, Inc. to Actinium Pharmaceuticals, Inc.
- Trading Symbol: The new trading symbol, ATNM, became effective on April 18, 2013.
Outlook, Risks, and Management Commentary
Management commentary is limited to the execution of the merger and name change. A press release dated April 17, 2013, regarding these changes is included as an exhibit. The filing does not contain specific guidance, risk factors, or contingencies related to future operations or financial outlook.
Investor Verification Checklist
- Confirm the effective date of the new trading symbol (ATNM) is April 18, 2013.
- Verify the legal status of the Delaware Certificate of Incorporation and Bylaws (Exhibits 3.1 and 3.2).
- Review the press release (Exhibit 99.1) for strategic rationale behind the name and domicile change.
- Check subsequent filings for the first financial report under the new corporate structure.